Search

Author/Creator Scholten, S

2. PEPDar: A randomized prospective noninferiority study of ritonavir‐boosted darunavir for HIV post‐exposure prophylaxis. Issue 6 (11th May 2016)

Authors:
Fätkenheuer, G; Jessen, H; Stoehr, A; Jung, N; Jessen, AB; Kümmerle, T; Berger, M; Bogner, JR; Spinner, CD; Stephan, C; Degen, O; Vogelmann, R; Spornraft‐Ragaller, P; Schnaitmann, E; Jensen, B; Ulmer, A; Kittner, JM; Härter, G; Malfertheiner, P; Rockstroh, J
Journal:
HIV medicine
Issue:
Volume 17:Issue 6(2016:Jul.)
Page Start:
453
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Rates of sustained virological response 12 weeks after the scheduled end of direct‐acting antiviral (DAA)‐based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy?. Issue 4 (25th January 2018)

Authors:
Bischoff, J; Mauss, S; Cordes, C; Lutz, T; Scholten, S; Moll, A; Jäger, H; Cornberg, M; Manns, MP; Baumgarten, A; Rockstroh, JK
Journal:
HIV medicine
Issue:
Volume 19:Issue 4(2018)
Page Start:
299
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗